Asia Pacific Drug Discovery Informatics Market Size & Outlook
Asia Pacific drug discovery informatics market, 2018-2030 (US$M)
Asia Pacific drug discovery informatics market highlights
- The Asia Pacific drug discovery informatics market generated a revenue of USD 744.2 million in 2023.
- The market is expected to grow at a CAGR of 11.9% from 2024 to 2030.
- In terms of segment, discovery informatics was the largest revenue generating work-flow in 2023.
- Discovery Informatics is the most lucrative work-flow segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 744.2 million |
| Market revenue in 2030 | USD 1,636.5 million |
| Growth rate | 11.9% (CAGR from 2023 to 2030) |
| Largest segment | Discovery informatics |
| Fastest growing segment | Discovery Informatics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Discovery Informatics |
| Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.8% of the global drug discovery informatics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,636.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Discovery informatics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific drug discovery informatics market based on discovery informatics covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to grow at a lucrative CAGR of 12.0% owing to improvement in health care infrastructure coupled with development initiatives taken up by pharmaceutical companies operating in this region.
Asia Pacific serves as a great pool of patients with respect to infectious diseases and thus is expected to drive the market growth. As this region contributes 60% in total world’s population, low prevalence translates into large numbers of infected people.
Emerging economies such as India and Australia also contribute towards the revenue share and growth of rest of Asia Pacific region. As outsourcing of the services is gaining momentum a greater number of Asian countries are involved in creating the infrastructure that is expected to support drug discovery.
Reasons to subscribe to Asia Pacific drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug discovery informatics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
